Wikidata

(Q39097112)

English

Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects

scientific article published on 13 December 2016

In more languages

Statements

title
Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
author name string
Takahiro Takase
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
Akinobu Nakamura
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
Hideaki Miyoshi
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
Chiho Yamamoto
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
Tatsuya Atsumi
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
publication date
13 December 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017
page(s)
363-367
1 reference
stated in
Europe PubMed Central
PubMed ID
27980239
retrieved
9 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39097112&oldid=1807323099"